GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Immunology market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Immunology market reports here.

NEW Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Cytokine Release Syndrome (Cytokine Storm) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cytokine Release Syndrome (Cytokine Storm) pipeline landscape....

NEW Cat Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • April 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Drugs In Development, 2022, provides an overview of the Cat Allergy (Immunology) pipeline landscape. Cat allergy is...

NEW Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • April 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Drugs In Development, 2022, provides an overview of the Grass Pollen Allergy (Immunology) pipeline landscape. Grass...

NEW Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,500
  • April 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Drugs In Development, 2022, provides an overview of the Bone Marrow Transplant Rejection (Immunology) pipeline...

NEW Microscopic Polyangiitis (MPA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Microscopic Polyangiitis (MPA) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

NEW Myasthenia Gravis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an...

NEW Systemic Sclerosis (Scleroderma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,500
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

NEW House Dust Mite Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update,...

NEW Birch Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

NEW Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,500
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an...